SpringWorks’ Mirdametinib Receives Positive CHMP Opinion for NF1-Associated Plexiform Neurofibromas in Europe

SpringWorks Therapeutics, Inc. , a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Europe...

May 26, 2025 | Monday | News
Juvena Therapeutics Begins Clinical Trial of JUV-161, a First-in-Class Muscle Regenerating Biologic for Myotonic Dystrophy

JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered ...

May 20, 2025 | Tuesday | News
Shanghai Ark Biopharma Reports Positive Phase II Results for AK3280 in IPF Patients Signaling New Hope in Fibrotic Lung Disease Treatment

Shanghai Ark Biopharmaceutical announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic...

May 16, 2025 | Friday | News
Illumina Unveils DRAGEN™ v4.4 with Breakthrough Accuracy and Oncology-Ready Applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling ...

May 14, 2025 | Wednesday | News
CellFE and Made Scientific Partner to Validate Scalable Non-Viral Gene Editing for T Cell Therapies

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization...

May 14, 2025 | Wednesday | News
Invenra Launches T-Body™ Trispecific Antibody Platform to Advance Next-Gen Multispecific Therapeutics

Invenra Inc., a pioneer in multispecific antibody discovery and development, announces the launch of its T-Body™ trispecific antibody platform, a n...

May 14, 2025 | Wednesday | News
OmniAb Showcases xPloration Platform at PEGS Boston to Transform Antibody Discovery with AI-Powered Single B-Cell Screening

xPloration Maximizes Impact for OmniAb’s Partners through Efficient and Precise Mining of Immunized Antibody Repertoires OmniAb, Inc. &n...

May 14, 2025 | Wednesday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News
BD Launches FACSDiscover™ A8 Cell Analyzer to Redefine Flow Cytometry with Spectral and Real-Time Imaging Technologies

BD a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral...

May 14, 2025 | Wednesday | News
Etcembly Partners with DJS Antibodies, Part of AbbVie, to Accelerate AI-Driven Antibody Discovery

British techbio innovator Etcembly has signed a collaboration agreement with DJS Antibodies, a part of AbbVie, to accelerate the discovery of novel antib...

May 13, 2025 | Tuesday | News
10x Genomics Reports Q1 2025 Revenue of $154.9M as CEO Serge Saxonov Shifts to Quarterly Guidance Amid Funding Uncertainty

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31...

May 09, 2025 | Friday | Company results
PL BioScience and DewCell Introduce First Artificial Human Platelet Lysate Enabling Scalable Xeno-Free Cell Therapy Manufacturing

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceutical...

May 09, 2025 | Friday | News
Qosina Partners with Sealed Air to Expand Bioprocessing Portfolio with NEXCEL® BIO1250 High-Performance Bag Film

Qosina, a global leader in the distribution of single-use medical and biopharmaceutical components, is proud to announce a new strategic partnership with...

May 09, 2025 | Friday | News
GeneFab and RegCell Unite to Accelerate U.S. Clinical Manufacturing of Next-Gen Treg Therapies

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCe...

May 08, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close